Implementing a Community-Based Response to the Opioid Epidemic in Rural Ohio - Supplement

对俄亥俄州农村地区的阿片类药物流行病实施基于社区的应对措施 - 补充材料

基本信息

  • 批准号:
    10644578
  • 负责人:
  • 金额:
    $ 15.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-15 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Ohio is experiencing one of the worst opioid injection epidemics in the country. The epidemic has severely affected rural Appalachian counties in southern Ohio, leading to a surge in overdose fatalities. Ohio's heroin- related overdose rate is five times the national rate. In addition to overdose deaths, HCV has increased 400% between 2009-2013 and neonatal abstinence syndrome (NAS) has increased 9-fold between 2004-2014. Many evidence-based interventions (EBI), such as syringe service programs, medication-assisted treatment for substance use, naloxone provision for overdose treatment, and testing for HCV, HIV and sexually transmitted diseases (STD) are known to be effective in combating injection drug addiction and its consequences. Unfortunately, little is known about how to apply lessons learned in urban injection drug epidemics to sparsely- populated rural areas. In rural Ohio, as in much of the U.S., the delivery of EBI is limited or fragmented. A lack of coordination between key agencies to address overlap and gaps in services, especially in the context of severely constrained resources, has dire consequences for those struggling with opioid injection drug use. The proposed study will develop and implement a service delivery plan for EBI that can be scaled up in rural Ohio as well as other rural areas in the US experiencing opioid epidemics. In the UG3 phase, we will use a mixed methods approach to assess the socio-cultural and political context of the epidemic across multiple levels, including agencies, health care and service providers, and people who inject drugs (PWID) within three counties in rural Appalachia. We will use respondent-driven sampling (RDS) to assess injection behaviors and HCV, HIV, and STD prevalence. Building on this multi-level formative data, we will identify service gaps and work closely with key community stakeholders to build consensus around and prioritize the most relevant, feasible and acceptable implementation strategies to deliver EBI that may include coalition building, data synthesis across counties, crowdfunding models, and telemedicine. In the UH3 phase, we will implement, monitor and evaluate our service delivery plan for opioid injectors, using a regression point displacement design and repeat RDS surveys. Outcomes will include overdose deaths, NAS cases, HCV and HIV tests performed, and referral for HCV and HIV care. Implementation outcomes will include acceptability, adoption, feasibility, fidelity, penetration, sustainability, and cost. Scalability will be assessed by applying lessons learned in the UG3 phase in three additional counties during the UH3. Upon completion of the study, we will have enhanced EBI service delivery in multiple counties in Ohio and developed an exportable model of service needs assessment, community-engaged decision-making, and implementation. This model will be suitable for use throughout rural American in settings where opioid addiction has been identified and existing service delivery is limited or fragmented.
项目摘要/摘要 俄亥俄州正在经历该国最糟糕的阿片类药物注射流行病之一。流行病严重 影响了俄亥俄州南部的阿巴拉契亚县,导致过量死亡人数激增。俄亥俄的海洛因 - 相关的过量率是国家利率的五倍。除了过量死亡之外,HCV还增加了400% 在2009 - 2013年之间,在2004 - 2014年之间,新生儿禁欲综合征(NAS)增加了9倍。许多 基于证据的干预措施(EBI),例如注射器服务计划,以药物辅助治疗 药物使用,用于过量治疗的纳洛酮以及HCV,HIV和性传播的测试 已知疾病(STD)有效地打击注射药物成瘾及其后果。 不幸的是,关于如何在城市注射药物流行中汲取的经验教训的知识知之甚少。 人口稠密的农村地区。在俄亥俄州农村地区,与美国大部分地区一样,EBI的交付是有限的或分散的。缺乏 关键机构之间协调以解决服务中的重叠和差距,尤其是在 严重限制的资源,对那些挣扎着阿片类药物注射药物使用的人产生了可怕的后果。 拟议的研究将制定并实施EBI的服务交付计划,可以扩大规模 俄亥俄州农村以及美国的其他农村地区正在经历阿片类药物流行病。在UG3阶段,我们将使用 一种评估多种流行病的社会文化和政治背景的混合方法 包括机构,医疗保健和服务提供者在内的级别以及在三个中注入毒品的人(PWID) 阿巴拉契亚农村地区的县。我们将使用受访者驱动的抽样(RDS)来评估注射行为和 HCV,艾滋病毒和性病患病率。在此多层形成数据的基础上,我们将确定服务差距和 与关键社区利益相关者紧密合作,以建立共识并确定最相关的,最相关的 可行且可接受的实施策略,以交付可能包括联盟建设,数据的EBI 跨县的合成,众筹模型和远程医疗。在UH3阶段,我们将实施 使用回归点位移监视和评估阿片类药物注射器的服务提供计划 设计和重复RDS调查。结果将包括过量死亡,NAS病例,HCV和HIV测试 进行,并转介HCV和HIV护理。实施结果将包括可接受性,采用, 可行性,忠诚,渗透,可持续性和成本。可伸缩性将通过应用课程来评估 在UH3期间的另外三个县的UG3阶段中。 研究完成后,我们将在俄亥俄州的多个县增强EBI服务交付 开发了可导出的服务需求评估模型,社区参与的决策以及 执行。该模型适合在阿片类药物的环境中在整个美国农村地区使用 已经确定了成瘾,现有的服务交付是有限或分散的。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis.
  • DOI:
    10.1186/s12954-024-00936-9
  • 发表时间:
    2024-01-17
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Estadt, Angela T.;White, Brian N.;Ricks, JaNelle M.;Lancaster, Kathryn E.;Hepler, Staci;Miller, William C.;Kline, David
  • 通讯作者:
    Kline, David
"You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.
  • DOI:
    10.1016/j.drugpo.2020.102704
  • 发表时间:
    2020-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Richard EL;Schalkoff CA;Piscalko HM;Brook DL;Sibley AL;Lancaster KE;Miller WC;Go VF
  • 通讯作者:
    Go VF
"I Was Raised in Addiction": Constructions of the Self and the Other in Discourses of Addiction and Recovery.
  • DOI:
    10.1177/1049732320948829
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Sibley AL;Schalkoff CA;Richard EL;Piscalko HM;Brook DL;Lancaster KE;Miller WC;Go VF
  • 通讯作者:
    Go VF
Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.
  • DOI:
    10.1007/s11904-018-0393-0
  • 发表时间:
    2018-06
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Schranz AJ;Barrett J;Hurt CB;Malvestutto C;Miller WC
  • 通讯作者:
    Miller WC
Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis.
  • DOI:
    10.1186/s12954-023-00892-w
  • 发表时间:
    2023-10-26
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Ballard, April M.;Falk, Dylan;Greenwood, Harris;Gugerty, Paige;Feinberg, Judith;Friedmann, Peter D.;Go, Vivian F.;Jenkins, Wiley D.;Korthuis, P. Todd;Miller, William C.;Pho, Mai T.;Seal, David W.;Smith, Gordon S.;Stopka, Thomas J.;Westergaard, Ryan P.;Zule, William A.;Young, April M.;Cooper, Hannah L. F.
  • 通讯作者:
    Cooper, Hannah L. F.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VIVIAN F. GO其他文献

VIVIAN F. GO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VIVIAN F. GO', 18)}}的其他基金

A brief alcohol intervention to reduce alcohol use and improve PrEP ouctomes among men who have sex with men: A randomized controlled trial in Vietnam
简短的酒精干预措施可减少男男性行为者的饮酒并改善 PrEP 结果:越南的一项随机对照试验
  • 批准号:
    10542097
  • 财政年份:
    2022
  • 资助金额:
    $ 15.74万
  • 项目类别:
A brief alcohol intervention to reduce alcohol use and improve PrEP ouctomes among men who have sex with men: A randomized controlled trial in Vietnam
简短的酒精干预措施可减少男男性行为者的饮酒并改善 PrEP 结果:越南的一项随机对照试验
  • 批准号:
    10705834
  • 财政年份:
    2022
  • 资助金额:
    $ 15.74万
  • 项目类别:
Scaling up the brief alcohol intervention to prevent HIV infection in Vietnam: a cluster randomized, implementation trial
在越南扩大短期酒精干预措施以预防艾滋病毒感染:一项整群随机实施试验
  • 批准号:
    10705221
  • 财政年份:
    2022
  • 资助金额:
    $ 15.74万
  • 项目类别:
Scaling up the brief alcohol intervention to prevent HIV infection in Vietnam: a cluster randomized, implementation trial
在越南扩大短期酒精干预措施以预防艾滋病毒感染:一项整群随机实施试验
  • 批准号:
    10542098
  • 财政年份:
    2022
  • 资助金额:
    $ 15.74万
  • 项目类别:
Vietnam Implementation Science Advancement: A Training Program to Improve HIV Prevention and Care
越南实施科学进步:改善艾滋病毒预防和护理的培训计划
  • 批准号:
    10244759
  • 财政年份:
    2021
  • 资助金额:
    $ 15.74万
  • 项目类别:
Vietnam Implementation Science Advancement: A Training Program to Improve HIV Prevention and Care
越南实施科学进步:改善艾滋病毒预防和护理的培训计划
  • 批准号:
    10374946
  • 财政年份:
    2021
  • 资助金额:
    $ 15.74万
  • 项目类别:
Vietnam Implementation Science Advancement: A Training Program to Improve HIV Prevention and Care
越南实施科学进步:改善艾滋病毒预防和护理的培训计划
  • 批准号:
    10594977
  • 财政年份:
    2021
  • 资助金额:
    $ 15.74万
  • 项目类别:
Scaling up HPTN 074: a Cluster Randomized Implementation Trial of an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam
扩大 HPTN 074:越南吸毒者抗逆转录病毒治疗循证干预的整群随机实施试验
  • 批准号:
    9981750
  • 财政年份:
    2018
  • 资助金额:
    $ 15.74万
  • 项目类别:
Scaling up HPTN 074: a Cluster Randomized Implementation Trial of an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam
扩大 HPTN 074:越南吸毒者抗逆转录病毒治疗循证干预的整群随机实施试验
  • 批准号:
    10197081
  • 财政年份:
    2018
  • 资助金额:
    $ 15.74万
  • 项目类别:
Scaling up HPTN 074: a Cluster Randomized Implementation Trial of an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam
扩大 HPTN 074:越南吸毒者抗逆转录病毒治疗循证干预的整群随机实施试验
  • 批准号:
    9768997
  • 财政年份:
    2018
  • 资助金额:
    $ 15.74万
  • 项目类别:

相似海外基金

A comparative evaluation of overdose prevention programs in New York City and Rhode Island
纽约市和罗德岛州药物过量预防计划的比较评估
  • 批准号:
    10629749
  • 财政年份:
    2023
  • 资助金额:
    $ 15.74万
  • 项目类别:
Development of antibody drug conjugates as pan-filo antivirals
开发作为泛型抗病毒药物的抗体药物偶联物
  • 批准号:
    10759731
  • 财政年份:
    2023
  • 资助金额:
    $ 15.74万
  • 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
  • 批准号:
    10495114
  • 财政年份:
    2023
  • 资助金额:
    $ 15.74万
  • 项目类别:
Intracellular functions and mechanisms of alphavirus ion channel 6K
甲病毒离子通道6K的细胞内功能和机制
  • 批准号:
    10727819
  • 财政年份:
    2023
  • 资助金额:
    $ 15.74万
  • 项目类别:
Point-of-care diagnostic test for T. cruzi (Chagas) infection
克氏锥虫(恰加斯)感染的即时诊断测试
  • 批准号:
    10603665
  • 财政年份:
    2023
  • 资助金额:
    $ 15.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了